Evidence map›Paper›PMID 27529054›Full record

ArticleCurrent otorhinolaryngology reports2016

Pathophysiology of Olfactory Disorders and Potential Treatment Strategies.

Stefania Goncalves, Bradley J Goldstein

Abstract read
In one paragraph

Article in Current otorhinolaryngology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Clinical characteristics of local allergic rhinitis sensitized to house dust mites in Asia.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  5. Review
  6. Intranasal Insulin for Treatment of Persistent Post-COVID-19 Olfactory Dysfunction: A Scoping Review.Journal of community hospital internal medicine perspectives · 2024
    Article
  7. Validity and Reliability of the Malay Questionnaire for Olfactory Disorders.The Malaysian journal of medical sciences : MJMS · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Review
  12. Olfactory training assists in olfactory recovery after sinonasal surgery.Laryngoscope investigative otolaryngology · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stefania GoncalvesDepartment of Otolaryngology and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.
Bradley J GoldsteinDepartment of Otolaryngology and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.

Funding

Nasal progenitor cells and olfactory neurogenesisK08DC013556 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GOLDSTEIN, BRADLEY J · 2014 to 2018
$1.1M
NIDCD NIH HHS K08 DC013556
6 · The paper itself

Abstract

Olfactory disorders have been regarded in the past with a sense of therapeutic nihilism. However, there have been remarkable advances in chemosensory research over the past several years. The clinical importance of olfactory disorders is well established, and entities such as presbyosmia have gained considerable broad attention. Powerful basic science experimental approaches have revealed aspects of olfactory neuron physiology, olfactory tissue maintenance and regeneration that provide new potential therapeutic targets for certain forms of olfactory dysfunction. Although many recent advances remain in pre-clinical stages, there is considerable reason for optimism regarding future approaches for treatment of patients with olfactory loss.

Indexed as

anosmiaciliopathyhyposmiaolfactionpost-viral olfactory disorderpresbyosmia

Identifiers

PMID27529054
PMCPMC4982703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.